Looking for
something specific?

I may have to take a drug based on these. Have you taken them and have you any advice?

Hi everyone, this is my first post here on Shift. It's good to be here! I'm posting because my wife has MS and she takes Gilenya daily as part of her treatment plan. As many of you may know, data shows that Gilenya doesn't allow the COVID vaccines to produce antibodies. We're trying to find ways to...

Hello, everyone. Due to complications, I am forced to take monoclonal antibodies. I am still to take Aquaporin 4 to see if I'm supposed to be on Nataluzimab or Rituximab. However, both medicines have to come from abroad as I live in the Philippines and is not covered by insurance. Can anyone please ...

An article I published on LinkedIn the other day: Or... Why Aren't MS Patients Worth It? Recently, I was sent a genetic test that won much acclaim at ECTRIMS 2023. The test is simple, fast, and unequivocal. Why is it important? As one of the 2.5 million plus Multiple Sclerosis (MS) patients in th...

Several of us here have been exposed to the technical, dare I say nerdy, language. Don't sweat it if it is gibberish. Start with the intro and conclusion. If you want to know anything specific about terms/abbreviations used then drop a question at the bottom. This is an interesting peer review - a...

So Sotrovimab which is the drug that the NHS is throwing at vulnerable COVID patients is a monoclonal antibody. AFAIK that's what Ocrevus/Ocrelizumab is (that I'm on), does that kill off it's usefulness? Could it cause problems?

I have well-controlled RRMS I recently tested positive for COVID and have had a few rough days but seem to be getting better Ive just been offered Sotrovimab a biological medicine for Covid. It's a neutralising monoclonal antibody - a man-made synthetic protein that mimics human antibodies. These s...

Hi, Just wanted to see if anyone else was able to get the monoclonal antibody infusion while they had CoVid. I tested positive at home but went into the clinic because I would be “flagged” as a potential candidate for the infusion. The offered it to me and it made a huge difference. I was struggl...

AstraZeneca's monoclonal antibody combination tixagevimab-cilgavimab (Evusheld) reduced the risk of symptomatic COVID-19 infection by 83% over placebo at a median follow-up of 6 months, finds a phase 3 randomized clinical trial published yesterday in the New England Journal of Medicine. It has emer...